Suppr超能文献

用于骨质疏松症临床评估的骨生物标志物:最新进展与未来展望

Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives.

作者信息

Kuo Tsung-Rong, Chen Chih-Hwa

机构信息

Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, 11031 Taiwan.

International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, 11031 Taiwan.

出版信息

Biomark Res. 2017 May 18;5:18. doi: 10.1186/s40364-017-0097-4. eCollection 2017.

Abstract

Bone biomarkers included formation, resorption and regulator are released during the bone remodeling processes. These bone biomarkers have attracted much attention in the clinical assessment of osteoporosis treatment in the past decade. Combination with the measurement of bone mineral density, the clinical applications of bone biomarkers have provided comprehensive information for diagnosis of osteoporosis. However, the analytical approaches of the bone biomarkers are still the challenge for further clinical trials. In this mini-review, we have introduced the functions of bone biomarkers and then recently developed techniques for bone biomarker measurements have been systematically integrated to discuss the possibility for osteoporosis assessment in the early stage.

摘要

骨生物标志物包括在骨重塑过程中释放的形成、吸收和调节标志物。在过去十年中,这些骨生物标志物在骨质疏松症治疗的临床评估中备受关注。结合骨密度测量,骨生物标志物的临床应用为骨质疏松症的诊断提供了全面信息。然而,骨生物标志物的分析方法仍然是进一步临床试验面临的挑战。在本综述中,我们介绍了骨生物标志物的功能,然后系统地整合了最近开发的骨生物标志物测量技术,以探讨早期评估骨质疏松症的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea3/5436437/772c1a57fa1d/40364_2017_97_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验